$ANET

Duda Kenneth sold $3.0M of ANET

Duda Kenneth (President and CTO) sold 17,333 shares of Arista Networks, Inc. (ANET) at an average of $171.42 ($167.35–$175.04, $2.97M total) across 9 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Duda Kenneth
Published Jun 24, 2026, 10:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 10:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ANET
Neutral
medium confidence
Mentioned
$ANET
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANETNeutralLow
01

Why it matters

The newest fact is the disclosed sale size (~17,333 shares; ~$2.97M) by the company’s President & CTO, executed across multiple trades at ~$167.35–$175.04 per share under a 10b5-1 plan.

02

Market read

This is a primary-source insider-selling datapoint; it may marginally affect sentiment but does not introduce new fundamentals.

03

What to watch

Traders may overreact to insider sales; the key differentiator here is the pre-arranged nature of the transactions, which reduces interpretive weight.

Relevance 5/10Novelty 5/10Timing: After-hours/filing update on 2026-06-24 for a 2026-06-22 insider sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Arista Networks, filed on 2026-06-24, covering sales executed on 2026-06-22.

Company-level read

Ticker impact

$ANETNeutralMedium confidence
Context

Arista Networks insider Kenneth Duda (President & CTO) sold ~$2.97M of ANET shares via an open-market sale under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived unless paired with other company-specific catalysts.

Evidence & confidence

The filing is a primary-source Form 4, but it specifies a pre-arranged 10b5-1 plan and does not disclose new operational or financial information.

Market effects

Minimal; insider selling at one networking software/hardware name typically does not reset sector fundamentals.

None indicated; event is company-specific and US-listed.

None indicated; no deal, guidance, or regulatory action affecting broader markets.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Arista Networks, Inc.

    US-listed networking company subject of the Form 4 insider sale disclosure.

  • Kenneth Duda

    President and CTO who sold shares via open-market transactions under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CSCOHighAI 9/10

Cisco Systems (CSCO) & Arista Networks (ANET): Cisco Just Beat Every Estimate. Why Did the Stock Still Drop 8%?

Cisco (CSCO) reported Q4 earnings and revenue beating estimates, with revenue up 18% YoY to $17.25B and net income up 51% to $3.9B. Despite strong results, shares dropped 8.4%. Arista (ANET) also beat estimates with Q2 revenue up 37.7% YoY to $3.036B, and its stock did not decline. Cisco's guidance was above expectations, but some analysts worry about growth peaking. Arista's growth is driven by hyperscaler and AI customers, similar to Cisco's concentration risk.

$ANETHighAI 8/10

Arista Networks Says AI Demand Broadens as Supply Limits Upside to 40% Growth Guide

Arista Networks (NYSE:ANET) reports AI demand is growing, but supply constraints limit revenue growth to 40%. The company's EOS software is key to its AI networking strategy. Arista is investing in scale-up and scale-across networking, with scale-up expected to become material post-2027. Gross margins are projected at 62-64%, and campus networking revenue is expected to rise to $1.25B. 1.6T product trials are underway, with volume production planned for next year.